The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
The company plans to add 1700 beds by FY27 through the organic route
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
Launch of Indian public health standards for Ayush healthcare facilities
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
These digital avenues have not only revolutionized patient care but also opened up new opportunities for HCPs to build thought leadership in their respective fields
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
